Repligen Corp - Company Profile
Powered by 
All the sales intelligence you need on Repligen Corp in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Repligen Corp fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Repligen Corp.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
Repligen Corp (Repligen) is a life science company that develops and commercializes bioprocessing technologies for the manufacturing of biological drugs. The company offers products such as upstream filtration, downstream filtration, chromatography, fluid management, cell culture supplements, ligands, process analytics, product configurators, and dialysis products. It also provides services including professional installation and qualification, calibration and maintenance service, spare parts and service plans, and custom solutions. The company markets its products under the brands such as XCell, KrosFlo, TFDF, ProConnex, TangenX, KR2i RPM, KRM, OPUS, LONG, NGL-Impact, PATsmart, and REBEL, among others. It operates in North America, Europe and Asia regions. Repligen is headquartered in Waltham, Massachusetts, the US.
Headquarters
United States of America
Address
Building 1, Suite 100, 41 Seyon Street, Waltham, Massachusetts, 02453
Website
www.repligen.com
Telephone
1 781 2500111
No of Employees
2,000
Industry
Medical Equipment
Ticker Symbol & Exchange
RGEN (NASD)
Revenue (2024)
$738.3M
16.4%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
291.6%
(2024 vs 2023)
Market Cap*
$7.0B
Net Profit Margin (2024)
XYZ
264.7%
(2024 vs 2023)
* As of and is in US$
Repligen Corp premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Upstream Filtration | Professional Installation and Qualification | Repligen |
| Alternating Tangential Flow (ATF) Filtration Systems | Calibration and Maintenance Service | XCell |
| Tangential Flow Depth Filtration (TFDF) Systems | Spare Parts and Service Plans | KrosFlo |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Contracts/Agreements | In September, the company partnered with Yokogawa Corporation of America to integrate OpreX Bio Pilot with its MAVERICK system, enabling the automated, real-time control of glucose and lactate in cell cultures without manual sampling or complex calibration models. |
| 2025 | Contracts/Agreements | In July, the company entered into a partnership with Novasign to integrate Novasign’s machine learning and modeling workflow into Repligen filtration systems. |
| 2025 | Contracts/Agreements | In July, the company partnered with Univercells Technologies to integrate the MAVEN Real Time Glucose Control Platform with Univercells' scale-X bioreactors, enhancing the development and manufacturing of viral vectors and vaccines. |
Competitor Comparison
| Key Parameters | Repligen Corp | Agilent Technologies Inc | Bio-Techne Corp | Rockwell Medical Inc | Nephros Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | Waltham | Santa Clara | Minneapolis | Wixom | South Orange |
| State/Province | Massachusetts | California | Minnesota | Michigan | New Jersey |
| No. of Employees | 2,000 | 17,900 | 3,100 | 244 | 36 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Martin Madaus, Ph.D | Chairman | Executive Board | 2023 | 66 |
| Olivier Loeillot | Chief Executive Officer; Director; President | Executive Board | 2024 | 56 |
| Jason K. Garland | Chief Financial Officer | Senior Management | 2023 | 52 |
| James Bylund | Chief Operating Officer | Senior Management | 2022 | 63 |
| Violetta Hughes | Chief Accounting Officer | Senior Management | 2025 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer